STOCK TITAN

Abacus Life, Inc. - ABL STOCK NEWS

Welcome to our dedicated page for Abacus Life news (Ticker: ABL), a resource for investors and traders seeking the latest updates and insights on Abacus Life stock.

Abacus Life, Inc. (NASDAQ: ABL) is a vertically integrated alternative asset manager specializing in investing in life insurance products throughout the lifecycle of a life insurance policy. Established in 2004, the company has carved a niche in the life settlement market, having purchased life insurance policies with over $5 billion in face value. Abacus Life serves consumers seeking liquidity by actively managing these policies through trading, holding, or servicing.

Abacus Life stands out for its detailed, data-driven approach to actuarial technology, democratizing the life insurance space via three key channels: ABL Tech, ABL Wealth, and ABL Longevity Growth & Income Funds. ABL Tech focuses on leveraging AI and innovative technology to enhance data security and operational efficiency, while ABL Wealth and ABL Longevity Funds offer tailored wealth management and investment solutions.

The company has achieved significant milestones, such as its recent $15 million stock repurchase program and the appointment of notable industry experts to its leadership team. They lead the market in funds paid to clients, holding a 26% market share in 2023, paying over $220 million to policyholders.

Abacus Life’s financial stability is evident in its impressive revenue growth, with total revenues for Q1 2024 doubling to $21.5 million compared to the previous year. They also maintain strong relationships with 78 institutional partners and 30,000 financial advisors and are accredited by the BBB with an A+ rating.

With operations in 49 states, Abacus Life is committed to maintaining the confidentiality of personal information, complying with HIPAA and privacy laws. Their stock is publicly traded on the Nasdaq Exchange under the ticker symbol ABL.

For more detailed information, visit their website at www.Abacuslife.com.

Rhea-AI Summary
Abacus Life, Inc. (NASDAQ: ABL) announces the release of its Fourth Quarter 2023 financial results on March 21, 2024. The company specializes in buying life insurance policies and managing specialty insurance products. A conference call will be held to discuss the results at 5:00 pm Eastern Time on the same day.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.2%
Tags
-
Rhea-AI Summary
Abacus Life, Inc. (NASDAQ: ABL) announces the official expansion of ABL Tech, its technology division, redefining the technological landscape within the pension fund and financial services industry. ABL Tech offers innovative solutions in mortality verification, valuation services, an enhanced life settlement marketplace, and blockchain technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.08%
Tags
none
-
Rhea-AI Summary
Abacus Life, Inc. (ABL) announces the official expansion of its technology division, ABL Tech, revolutionizing the pension fund and financial services industry with innovative tech-driven solutions. ABL Tech offers services like DeathTrac & LifeTrac, Valuation Services, Abacus Marketplace, and Blockchain Technology, aiming to simplify processes and enhance security.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.08%
Tags
none
Rhea-AI Summary
Abacus Life, Inc. (NASDAQ: ABL) updates its $15 million stock repurchase program, repurchasing 553,150 shares at an average price of $10.92, totaling $6.0 million. The company has $9.0 million remaining under the program, expiring on June 10, 2025. Chairman and CEO Jay Jackson expresses satisfaction with the progress, highlighting long-term growth opportunities to create value for stockholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.3%
Tags
buyback
-
Rhea-AI Summary
Abacus Life, Inc. announced a public offering of $25 million in 9.875% notes due 2028, bringing the total outstanding to $60,650,000. The Company aims to use the proceeds for debt refinancing and general corporate purposes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.01%
Tags
-
Rhea-AI Summary
Abacus Life, Inc. CEO Jay Jackson appeared on the Wealthion Podcast hosted by Eric Chemi to discuss the company's role as a leading buyer of life insurance policies and alternative asset manager. The podcast aims to address misconceptions about the industry and highlight Abacus Life's expertise in specialty insurance products.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.4%
Tags
none
Rhea-AI Summary
Abacus Life, Inc. CEO Jay Jackson discusses the de-SPAC process and the importance of longevity data on the SPACInsider Podcast. He emphasizes the potential for better financial products and allocations through accurate lifespan data. The podcast is available on Apple Podcasts, Spotify, and the SPACInsider website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.6%
Tags
none
-
Rhea-AI Summary
Abacus Life, a leading buyer of life insurance policies and alternative asset manager (NASDAQ: ABL), has provided an update on its $15 million stock repurchase program. Since the commencement of the program, the company has repurchased 206,050 shares of its common stock at an average price of $9.26, totaling approximately $1.9 million. As of January 9, 2024, Abacus has $13.1 million of availability under the Repurchase Program, which expires on June 10, 2025. The company's Chairman and CEO, Jay Jackson, expressed confidence in the quality of their business and the opportunities for long-term value creation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.24%
Tags
buyback
-
Rhea-AI Summary
Abacus Life, a leading buyer of life insurance policies and alternative asset manager, announced a new stock repurchase program of up to $15 million of the Company's outstanding common stock. The program reflects the Board's confidence in the business model and aims to create long-term value for shareholders. The Company may repurchase shares through various methods over a period of up to 18 months, with the timing and value of repurchases determined at the Company's discretion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.59%
Tags
buyback
Rhea-AI Summary
Abacus Life, Inc. (NASDAQ: ABL) reported strong Q3 2023 results, with total revenue growing 20% year-over-year to $21.1 million. The company also increased originations capital deployment by 43% year-over-year to $51 million. GAAP net income was $0.9 million, while non-GAAP adjusted net income stood at $9.2 million. Adjusted EBITDA grew 26% year-over-year to $10.8 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.61%
Tags

FAQ

What is the current stock price of Abacus Life (ABL)?

The current stock price of Abacus Life (ABL) is $8.34 as of November 15, 2024.

What is the market cap of Abacus Life (ABL)?

The market cap of Abacus Life (ABL) is approximately 613.9M.

What does Abacus Life, Inc. specialize in?

Abacus Life specializes in investing and managing life insurance products throughout the lifecycle of a policy.

What recent achievements has Abacus Life accomplished?

Abacus Life has recently led the industry in funds paid to clients with a 26% market share in 2023 and launched several strategic initiatives including a $15 million stock repurchase program.

How is Abacus Life democratizing the life insurance space?

Abacus Life is democratizing the life insurance space through its innovative channels: ABL Tech, ABL Wealth, and ABL Longevity Growth & Income Funds, leveraging data-driven technology and strategic wealth management.

What are Abacus Life's financial highlights for Q1 2024?

For Q1 2024, Abacus Life reported a total revenue of $21.5 million, more than doubling from the previous year, driven by higher active management revenue and increased policy originations.

Who are the recent key hires at Abacus Life?

Recent key hires include Elena Plesco as Chief Capital Officer and Fei Xue as Vice President of ABL Wealth, both bringing significant experience in asset management and investment.

What makes Abacus Life unique in the life settlement industry?

Abacus Life is the only public life settlement company, providing exceptional value to clients with a market-leading rate of over 20% of policy face value paid to sellers.

How does Abacus Life ensure the confidentiality of personal information?

Abacus Life complies with HIPAA and privacy laws to maintain and protect the confidentiality of financial, health, and medical information.

Where is Abacus Life's stock traded?

Abacus Life's stock is publicly traded on the Nasdaq Exchange under the ticker symbol ABL.

What is Abacus Life's approach to technology and innovation?

Abacus Life leverages AI and innovative technology through ABL Tech to introduce advanced solutions like AI-driven death verification, valuation services, and a blockchain-based marketplace.

What partnerships does Abacus Life have to enhance its distribution network?

Abacus Life has formed a new national distribution relationship with AIMCOR, enhancing their ability to offer life settlement solutions to a broad network of financial professionals and clients.

Abacus Life, Inc.

Nasdaq:ABL

ABL Rankings

ABL Stock Data

613.86M
74.68M
82.88%
17.39%
0.9%
Insurance - Life
Investment Advice
Link
United States of America
ORLANDO